Vanda Pharmaceuticals, Inc.
NASDAQ: VNDA
$6.11
+$0.12 (+2.0%)
Closing price May 26, 2023
Friday afternoon's top analyst upgrades and downgrades included BP, Carvana, Iron Mountain, Latch and LivePerson.
1 year ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Amazon, Caterpillar, Disney, EA, Target and more.
2 years ago
Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.
2 years ago
Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.
2 years ago
Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
2 years ago
Last Updated: 1 year ago
Vanda Pharma shares dropped early to start out the week after the frim announced that it received a Complete Response Letter from the FDA.
3 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and initiations seen on Thursday included Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify, Western Digital and Whiting Petroleum.
3 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and initiations seen on Thursday included AT&T, Caterpillar, Dollar General, Electronic Arts, Etsy, Facebook, Spirit Airlines, Tesla and Xilinx.
3 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and initiations seen on Wednesday included DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap and Vishay.
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Apple, Apptio, Cheniere Energy, First Solar, Kratos Defense & Security Solutions, Smartsheet,...
4 years ago
Last Updated: 3 years ago
Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients with idiopathic and diabetic gastroparesis.
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess and Western Digital.
5 years ago
Last Updated: 3 years ago
Needless to say, the past two years have been rough on biotech. The question for investors is which of the stocks hold the best potential in 2017.
6 years ago
Last Updated: 3 years ago
Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good sense now and have outstanding upside potential.
6 years ago
Last Updated: 3 years ago